OMERS Administration Corp’s Ironwood Pharmaceuticals IRWD Stock Holding History

OMERS Administration Corp’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$669K	Sell	159,010 -67,300	-30%	-$259K	﹤0.01%	762
2026 Q1	$794K	Buy	226,310 +11,200	+5%	+$45.9K	0.01%	699
2025 Q4	$725K	Hold	215,110	–	–	0.01%	591
2025 Q3	$282K	Hold	215,110	–	–	﹤0.01%	900
2025 Q2	$154K	Hold	215,110	–	–	﹤0.01%	799
2025 Q1	$316K	Hold	215,110	–	–	﹤0.01%	848
2024 Q4	$953K	Sell	215,110 -105,300	-33%	-$427K	0.01%	542
2024 Q3	$1.32M	Sell	320,410 -12,800	-4%	-$68.8K	0.01%	473
2024 Q2	$2.17M	Buy	+333,210	New	+$2.36M	0.02%	358
2019 Q3	–	Sell	-58,600	Closed	-$650K	–	447
2019 Q2	$650K	Buy	+58,600	New	+$656K	0.01%	321

Other funds holding IRWD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

OMERS Administration Corp's IRWD Position: Q2 2026 in Review

OMERS Administration Corp reduced its Ironwood Pharmaceuticals (IRWD) stake by 30% in Q2 2026, selling an estimated $259K and leaving 159,010 shares worth $669K. The position accounts for ﹤0.01% of the portfolio, ranked #762.

OMERS Administration Corp first reported a position in IRWD in Q2 2019 and has held it in 10 quarters since. The position peaked at $2.17M in Q2 2024. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

OMERS Administration Corp held 159,010 shares of Ironwood Pharmaceuticals worth $669K as of Q2 2026.
OMERS Administration Corp sold 67,300 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $259K.
Ironwood Pharmaceuticals made up ﹤0.01% of OMERS Administration Corp's portfolio in Q2 2026, its #762 holding.
OMERS Administration Corp first reported a position in Ironwood Pharmaceuticals in Q2 2019 and has held it in 10 quarters since.
OMERS Administration Corp's Ironwood Pharmaceuticals position peaked at $2.17M in Q2 2024.
212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.